Pfizer describes absorption of Wyeth ops; NanoSonic to make pulse-dried APIs;

> A Pfizer senior VP describes the big pharma's initiative to integrate manufacturing and outsourcing activities in the wake of the Wyeth acquisition. 12-minute Podcast

> CTD Holdings has launched NanoSonic Products, a subsidiary with the goal of using pulse dryer technology to produce c-GMP dry APIs by end of year. Release

> Canadian regulators have given Dynavax the go-ahead to start testing the lot-to-lot consistency of commercial vaccine and to complete the safety database for the HEPLISAV hepatitis B vaccine candidate. Announcement

> Quebec-based vaccine developer Medicago, which uses virus-like particle and proprietary manufacturing technologies, will present at this week's 6th WHO meeting on evaluation of pandemic influenza prototype vaccines in clinical trials. Release

> Linguamatics, a U.K.-based text-mining platform provider for life sciences enterprises, has opened a U.S. facility in Newton, MA, just outside Boston. Release